L-Histidine

组氨酸

Report date: 2023/07/28 10:20:22

Base Information

Drug NameL-Histidine
Drug Alias NameL-组氨酸Histidine
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionCarbonic anhydrase I activators
TargetsCarbonic anhydrase I
Therapy Area/IndicationsParenteral NutritionKidney Failure, ChronicAcute Kidney Injury +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsParenteral NutritionKidney Failure, ChronicAcute Kidney Injury +[8
Inactive IndicationsN/A

Other Information

ATC CodeB02AAB05BA01B05XB
Related LinksN/A